Welcome to our dedicated page for Claritev SEC filings (Ticker: CTEV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Claritev Corporation (NYSE: CTEV) files a range of documents with the U.S. Securities and Exchange Commission that detail its operations as a healthcare technology, data and insights company. As an issuer of Class A common stock listed on the New York Stock Exchange, Claritev provides investors with periodic and current reports that describe its financial performance, capital structure, client relationships and key corporate events.
On this page, you can access Claritev’s SEC filings, including current reports on Form 8-K that the company uses to announce material developments. Recent 8-K filings have covered topics such as quarterly financial results, contract renewals with its ten largest clients, underwriting agreements for secondary offerings of Class A common stock by selling stockholders, and changes in executive roles. These filings also confirm that Claritev’s Class A common stock, with a par value of $0.0001 per share, is registered under Section 12(b) and trades under the symbol CTEV on the NYSE.
Claritev’s earnings-related filings and exhibits provide detail on revenues, net income or loss, and non-GAAP metrics such as EBITDA, Adjusted EBITDA, Free Cash Flow, Unlevered Free Cash Flow and an Adjusted cash conversion ratio. The company defines these measures and explains their limitations, giving investors insight into how management evaluates performance and cash generation alongside GAAP results.
Through Stock Titan, these filings are complemented by AI-powered summaries that help explain the significance of each document. Investors can quickly see the key points from Claritev’s 8-Ks, and, where available, review annual reports on Form 10-K, quarterly reports on Form 10-Q, proxy materials and other disclosures. This page also provides a pathway to monitor any insider-related filings, such as Form 4 reports, that may be associated with Claritev’s equity compensation and ownership changes, offering a structured view of the company’s regulatory reporting history.
Claritev Corporation renewed contracts with its ten largest clients during 2025, a group that represented approximately 70% of total 2024 revenues. The renewals include automatically renewing agreements that were each renewed for one year.
Excluding clients with automatic one-year renewals, these largest clients accounted for approximately 57% of 2024 revenues. Within this group, the weighted average contract term is greater than three years, excluding the one-year automatic renewals. Claritev highlights continued focus on affordability, transparency, and quality through technology and AI across its enterprise platform.
Claritev Corp (CTEV) insider filing: the SVP, Chief Growth Officer reported a Form 4 for an RSU vesting event on 10/14/2025. The filing shows 7,684 Class A shares were withheld to cover taxes (Code F) at $55.26 per share, a non‑open‑market transaction tied to restricted stock unit vesting. Following this tax withholding, the officer directly holds 107,891 Class A shares.
Claritev Corp (CTEV) officer Albinson Brock reported a non‑derivative acquisition of 2,825 Class A common shares on 09/30/2025 via a restricted stock unit grant recorded at $0. The filing shows these RSUs vest in equal annual installments of 25% on each September 30, 2026, 2027, 2028 and 2029. Following the reported transaction, Mr. Brock is shown as beneficially owning 2,825 shares. The Form 4 was executed by an attorney‑in‑fact signature dated 10/01/2025 and identifies the reporting person as SVP, Chief Accounting Officer.
Claritev Corp (CTEV) Form 3: Brock Albinson filed an initial Form 3 reporting his status as Senior Vice President and Chief Accounting Officer and a director of Claritev Corp. The filing states that he does not beneficially own any securities of the issuer as of the event date 09/29/2025. The form was signed by an attorney-in-fact on 10/01/2025. No holdings, options, warrants, or other derivative positions are listed in the report.
Claritev Corporation appointed Brock Albinson as Senior Vice President, Chief Accounting Officer and principal accounting officer, effective September 29, 2025, replacing Gerald Kozel. Albinson brings extensive accounting leadership experience, having held senior financial roles at Automatic Data Processing, Inc. from 2007 to 2024, including Corporate Controller and Principal Accounting Officer from 2015 to 2024, and earlier experience at PricewaterhouseCoopers.
His compensation includes a starting annual base salary of $375,000 and eligibility for an annual cash incentive award targeted at 50% of earned base salary, beginning with 2025. Starting in 2026, he will be eligible for long-term incentive awards with an annual grant target equal to 150% of base salary, subject to Compensation Committee approval. On September 30, 2025, the Company plans to grant him restricted stock units valued at $150,000, vesting in equal annual installments over four years, subject to continued employment and plan terms.